"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Descriptor ID |
D009369
|
MeSH Number(s) |
C04
|
Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 7 | 4 | 11 |
1996 | 7 | 2 | 9 |
1997 | 13 | 0 | 13 |
1998 | 16 | 2 | 18 |
1999 | 8 | 6 | 14 |
2000 | 6 | 1 | 7 |
2001 | 10 | 4 | 14 |
2002 | 21 | 8 | 29 |
2003 | 28 | 10 | 38 |
2004 | 24 | 9 | 33 |
2005 | 34 | 7 | 41 |
2006 | 22 | 5 | 27 |
2007 | 38 | 7 | 45 |
2008 | 36 | 17 | 53 |
2009 | 51 | 5 | 56 |
2010 | 55 | 14 | 69 |
2011 | 54 | 15 | 69 |
2012 | 56 | 12 | 68 |
2013 | 68 | 16 | 84 |
2014 | 95 | 18 | 113 |
2015 | 68 | 11 | 79 |
2016 | 69 | 11 | 80 |
2017 | 99 | 15 | 114 |
2018 | 104 | 14 | 118 |
2019 | 78 | 11 | 89 |
2020 | 113 | 14 | 127 |
2021 | 108 | 8 | 116 |
2022 | 98 | 2 | 100 |
2023 | 99 | 5 | 104 |
2024 | 77 | 29 | 106 |
2025 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors. Oncologist. 2025 Jan 17; 30(1).
-
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies. Clin Cancer Res. 2025 Jan 17; 31(2):288-298.
-
Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex. Clin Cancer Res. 2025 Jan 17; 31(2):234-244.
-
Application and Expectations for Immune Checkpoint Blockade of LAG3 and TIGIT. Annu Rev Med. 2025 Jan; 76(1):189-205.
-
A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors. J Transl Med. 2025 Jan 09; 23(1):37.
-
How to Use Imaging: Complex Cases of Atherosclerosis, Myocardial Inflammation, and Cardiomyopathy in Cardio-Oncology. Circ Cardiovasc Imaging. 2025 Jan; 18(1):e015981.
-
Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions. Pediatr Blood Cancer. 2025 Mar; 72(3):e31532.
-
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing. J Immunother Cancer. 2025 Jan 08; 13(1).
-
The increasing global burden of cancer: implications for anaesthesia and peri-operative medicine. Anaesthesia. 2025 Feb; 80 Suppl 2:3-11.
-
Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind Trial. J Natl Compr Canc Netw. 2025 01 07; 23(1).